FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.

A growing body of research demonstrating the safety and effectiveness of self-managed abortion with pills, coupled with the ...

In as little as five minutes, the Daily Caller News Foundation was able to easily order abortion pills opponents argue ...

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically significant ...

A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results ...

Israel launches strikes on missile facilities in central Iran: air force Incyte (Nasdaq:INCY) today announced the first clinical data from two studies evaluating the safety, tolerability and efficacy ...

The Motley Fool. DATE Tuesday, June 17, 2025, at 4:30 p.m. EDT CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

Notably, GZR4 injection achieved superior HbA1c reduction in patients with inadequate glycemic control on prior basal insulin therapy compared to once-daily insulin degludec (Tresiba®).

Sanofi & Regeneron’s Dupixent receives US FDA approval to treat patients with bullous pemphigoid: Paris Saturday, June 21, 2025, 12:00 Hrs [IST] The US Food and Drug Administrat ...

The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in adults with alkaptonuria, Cycle ...